it might sound like a lot of busywork, but again these older drugs are the ones in greater use than your drugs. they could then be redacted electronically than the way your drugs are. it would be nice to as a more organizeal approach rather than looking in these different places. one place for an advisory committee -- and i didn't complain about advisory committee doctrine. you have to know basically where it was and when it was. rather than having that indexing method, why not have an index by drug and also have it index by indication. so if you're looking for depression, you could find drugs and also find dwieevices that a approved for depression. and then you can find the drug approval package, of course. and then you can find also perhaps the new complete response letters, if that indeed is going to come to pass. fun pediatric approval documents and the advisory committee documents. so just some -- just about out of time, so on the topic of advisory committee, i just want to make a plea, just a suggestion that we are talking -- this is symposium on transparency at the fda. why not an